Free Trial

Elevation Oncology (ELEV) Earnings Date, Estimates & Call Transcripts

Elevation Oncology logo
$0.35 +0.01 (+2.91%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$0.35 0.00 (0.00%)
As of 05/2/2025 05:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Elevation Oncology Earnings Summary

Latest Q4
Earnings Date
Mar. 6Estimated
Consensus EPS
(Mar. 6)
-$0.22
Actual EPS
(Mar. 6)
-$0.18 Beat By $0.04

Elevation Oncology released Q4 2024 earnings on March 6, 2025, reporting an EPS of -$0.18, which topped the consensus estimate of -$0.22 by $0.04. With a trailing EPS of -$0.81, Elevation Oncology's earnings are expected to decrease next year, from ($0.84) to ($0.89) per share.

Q4 2024 Earnings Resources

Get Elevation Oncology Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elevation Oncology and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ELEV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Elevation Oncology Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20253-$0.27-$0.21-$0.24
Q2 20254-$0.29-$0.20-$0.23
Q3 20254-$0.23-$0.19-$0.21
Q4 20254-$0.24-$0.20-$0.22

Elevation Oncology Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
3/6/2025Q4 2024-$0.22-$0.18+$0.04-$0.18--
11/6/2024--$0.20-$0.22 -$0.02-$0.22--
8/6/2024--$0.23-$0.18+$0.05-$0.18--
5/2/2024Q1 2024-$0.21-$0.23 -$0.02-$0.23--
3/6/2024Q4 2023-$0.21-$0.19+$0.02-$0.19--
11/2/2023Q3 2023-$0.34-$0.25+$0.09-$0.25--
8/3/2023Q2 2023-$0.28-$0.37 -$0.09-$0.37--
5/15/2023Q1 2023-$0.51-$0.50+$0.01-$0.28--

Elevation Oncology Earnings - Frequently Asked Questions

Elevation Oncology (NASDAQ:ELEV) last announced its quarterly earning data on Thursday, March 6, 2025. Learn more on ELEV's earnings history.

In the previous quarter, Elevation Oncology (NASDAQ:ELEV) reported ($0.18) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.22) by $0.04. Learn more on analysts' earnings estimate vs. ELEV's actual earnings.

Elevation Oncology (NASDAQ:ELEV) has a recorded net income of -$45.70 million. ELEV has generated -$0.81 earnings per share over the last four quarters.

Elevation Oncology's earnings are expected to decrease from ($0.84) per share to ($0.89) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:ELEV) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners